Centaur Animal Health appoints Jeffrey Boily as the new President, CEO, and Director, effective September 1, 2013. Mark Metrokotsas, the current CEO, will become the Chairman of the Board of Directors. Boily has over 30 years of global life sciences experience. He will help accelerate Centaur's plans to become a major animal health company by in-licensing additional products. Centaur has established a track record of successful product initiatives.

1. Centaur Animal Health Appoints New President and Chief
Executive Officer.
KANSAS CITY, Kan. and PHILADELPHIA, Aug. 27, 2013 /PRNewswire/ -- Centaur Animal
Health, is pleased to announce the appointment of Jeffrey Boily as President, CEO, and
Director effective September 1, 2013.
Mark Metrokotsas, who has been the CEO, will become Chairman of Centaur's Board of
Directors.
Boily brings over 30 years of global life sciences experience in pharmaceuticals, biotechnology,
drug delivery and animal health and will be instrumental in accelerating plans toward Centaur
becoming a major animal health company. Centaur has established a track record of
successful execution on product initiatives and is aggressively looking to in-license additional
products.
"I'm delighted to lead Centaur Animal Health as we embark on the next phase of growth," said
Boily.
"Jeff's background as an entrepreneurial leader and his experience in fund-raising and
partnering with large and small firms is a perfect fit for Centaur," said Mark Metrokotsas, Board
Chair for Centaur Animal Health.
Jeffrey Boily is non-executive Chairman of ProteaPex Therapeutics, a firm researching and
developing innovative animal health therapeutics. Most recently he was President and CEO of
the Center for Animal Health Innovation which focused on identifying and funding breakthrough
technologies. Previous to this, he was CEO of BioWizard, a VC funded research and
information firm for biomedical scientists. He gained large company executive experience at
Abbott, Rogers and Wyeth including Fort Dodge Animal Health. He holds an M.B.A. from the
John Molson School of Business, Concordia U., Montreal and a B.S. in biology from the U. of
Ottawa. He also serves on the Board of Directors of various healthcare companies.
About Centaur Animal Health
Centaur Animal Health is focused on developing innovative diagnostics, pharmaceuticals and
nutraceuticals that address significant therapeutic needs for companion and production
animals. Centaur licenses patent-protected technologies acquired from animal health or human
pharmaceutical and biotechnology companies. Contract manufacturing is available in their FDA
certified plant. For more information, please visit www.centauranimalhealth.com
Centaur Animal Health Appoints New President and Chief Exec... http://www.printthis.clickability.com/pt/cpt?expire=&title=Cent...
1 of 2 4/24/14, 12:26 PM

2. For Media:
Jeffrey Boily
Centaur Animal Health
O: (484) 619-3685
Jeff.Boily@centauranimalhealth.com
Web Site: http://www.centauranimalhealth.com
SOURCE Centaur Animal Health
RELATED LINKS
http://www.centauranimalhealth.com
Find this article at:
http://www.prnewswire.com/news-releases/centaur-animal-health-appoints-new-president-and-chief-executive-officer-221307291.html
Check the box to include the list of links referenced in the article.
Centaur Animal Health Appoints New President and Chief Exec... http://www.printthis.clickability.com/pt/cpt?expire=&title=Cent...
2 of 2 4/24/14, 12:26 PM